Related Experiment Video
Updated: Sep 11, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
Published on: September 4, 2017
Technical note: A PBS source model based independent dose calculation frame on TOPAS MC
Xuying Shang1, Yaoying Liu2, Xiaoyun Le3
1School of Physics, Beihang University, Beijing 102206, People's Republic of China; Department of Radiation Oncology, PLA General Hospital, Beijing 100853, People's Republic of China; Hebei Yizhou Tumor Hospital, Hebei, Zhuozhou 072750, People's Republic of China; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, People's Republic of China.
We developed a Monte Carlo (MC) platform for proton therapy dose calculations, independent of treatment planning systems. This versatile framework enables accurate dose verification and supports scientific research in particle therapy.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Science
Background:
- Monte Carlo (MC) simulations are crucial for accurate dose calculation in particle therapy.
- Existing MC platforms often rely on specific treatment planning systems (TPS), limiting their versatility.
- Developing an independent MC platform enhances flexibility and applicability in research and clinical settings.
Purpose of the Study:
- To establish a versatile Monte Carlo (MC) dose calculation platform independent of treatment planning systems (TPS).
- To create a comprehensive methodology for building such a platform for proton therapy.
- To enable accurate dose verification and support scientific research in particle therapy.
Main Methods:
- Optimized phase space parameters and beam source models in the source emission plane.
- Developed an automated method to convert patient plans into executable MC scripts for TOPAS MC software.
- Established a library of source model parameters for reproducible simulations.
Main Results:
- Achieved excellent agreement between simulated and measured beam spot sizes (<0.3 mm).
- Demonstrated high accuracy in depth-dose curve falloff (<0.1 mm) and point-to-point dose differences (<0.7%).
- Attained 100% 3D gamma passing rates for spread-out Bragg peaks and high rates for patient plans (99.96%-100%).
Conclusions:
- Successfully developed a comprehensive MC framework for pencil beam scanning (PBS) proton therapy.
- The framework utilizes a well-defined beam source model for accurate dose calculations.
- This methodology facilitates the development of dose verification tools and advances scientific research in particle therapy.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...